If you liked this article you might like

Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq

Cigna Is Ready for a Dealmaking Spree If and When Anthem Deal Is Officially Killed

Allergan's Fourth-Quarter Comments Should Comfort Investors

Allergan Followers Optimistic Ahead of Wednesday's Fourth-Quarter Report

Biotech Premarket Movers: PharmAthene, Earth Science Tech, Pulmatrix